{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:48:40Z","timestamp":1791701320919,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2008-2231-20-6","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T10:14:42Z","timestamp":1346148882000},"source":"Crossref","is-referenced-by-count":4,"title":["Combination therapy for airflow limitation in COPD"],"prefix":"10.1186","volume":"20","author":[{"given":"Mostafa","family":"Ghanei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Hoseini","family":"Nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Amini","family":"Harandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Alaeddini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Shohrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"64_CR1","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1378\/chest.123.5.1684","volume":"123","author":"RJ Halbert","year":"2003","unstructured":"Halbert RJ, Isonaka S, George D, Iqbal A: Interpreting COPD prevalence estimamtes: what is the true burden of disease?. Chest. 2003, 123: 1684-1692. 10.1378\/chest.123.5.1684.","journal-title":"Chest"},{"key":"64_CR2","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee Committee GOLD Scientific: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care. 2001, 163: 1256-1276.","journal-title":"Am J Respir Crit Care"},{"key":"64_CR3","first-page":"261","volume":"56","author":"A Gulsvik","year":"2001","unstructured":"Gulsvik A: The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis. 2001, 56: 261-264.","journal-title":"Monaldi Arch Chest Dis"},{"key":"64_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1590\/S1806-37132007000600017","volume":"33","author":"KL Irion","year":"2007","unstructured":"Irion KL, Hochhegger B, Marchiori E, Porto Nda S, Baldisserotto Sde V, Santana PR: Chest X-ray and computed tomography in the evaluation of pulmonary emphysema. J Bras Pneumol. 2007, 33: 720-732. 10.1590\/S1806-37132007000600017.","journal-title":"J Bras Pneumol"},{"key":"64_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001, 163: 1256-1276.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1183\/09031936.03.00040703","volume":"22","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003, 22: 672-688. 10.1183\/09031936.03.00040703.","journal-title":"Eur Respir J"},{"key":"64_CR7","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1164\/ajrccm.160.6.9904097","volume":"160","author":"AT Hill","year":"1999","unstructured":"Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA: Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with a1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med. 1999, 160: 1968-1975.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR8","doi-asserted-by":"publisher","first-page":"380S","DOI":"10.1378\/chest.117.5_suppl_2.380S","volume":"117","author":"S Sethi","year":"2000","unstructured":"Sethi S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000, 117: 380S-385S. 10.1378\/chest.117.5_suppl_2.380S.","journal-title":"Chest"},{"key":"64_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1164\/ajrccm.163.2.2003122","volume":"163","author":"SD Aaron","year":"2001","unstructured":"Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE: Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 163: 349-355.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1183\/09031936.01.99114901","volume":"17","author":"S Gompertz","year":"2001","unstructured":"Gompertz S, O\u2019Brien C, Bayley DL, Hill SL, Stockley RA: Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001, 17: 1112-1119. 10.1183\/09031936.01.99114901.","journal-title":"Eur Respir J"},{"key":"64_CR11","doi-asserted-by":"publisher","first-page":"136S","DOI":"10.1378\/chest.121.5_suppl.136S","volume":"121","author":"JA Wedzicha","year":"2002","unstructured":"Wedzicha JA: Exacerbations. Etiology and pathophysiologic mechanisms. Chest. 2002, 121: 136S-141S. 10.1378\/chest.121.5_suppl.136S.","journal-title":"Chest"},{"key":"64_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/srin.2003.50007","volume":"18","author":"MP Pietila","year":"2003","unstructured":"Pietila MP, Thomas CF: Inflammation and infection in exacerbations of chronic obstructive pulmonary disease. Sem Resp Inf. 2003, 18: 9-16. 10.1053\/srin.2003.50007.","journal-title":"Sem Resp Inf"},{"key":"64_CR13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/thorax.58.8.680","volume":"58","author":"AJ White","year":"2003","unstructured":"White AJ, Gompertz S, Bayley DL, Hill SL, O\u2019Brien C, Unsal I, Stockley RA: Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax. 2003, 58: 680-685. 10.1136\/thorax.58.8.680.","journal-title":"Thorax"},{"key":"64_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.coph.2004.12.005","volume":"5","author":"IK Demedts","year":"2005","unstructured":"Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA: Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol. 2005, 5: 257-263. 10.1016\/j.coph.2004.12.005.","journal-title":"Curr Opin Pharmacol"},{"key":"64_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1164\/ajrccm.156.2.9611013","volume":"156","author":"JE Repine","year":"1997","unstructured":"Repine JE, Bast A, Lankhorst I: Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997, 156: 341-357.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0014-2999(01)01320-6","volume":"429","author":"W Macnee","year":"2001","unstructured":"Macnee W: Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol. 2001, 429: 195-207. 10.1016\/S0014-2999(01)01320-6.","journal-title":"Eur J Pharmacol"},{"key":"64_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1164\/ajrccm.151.5.7735589","volume":"151","author":"JR Britton","year":"1995","unstructured":"Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, Lewis SA, Tattersfield AE, Weiss ST: Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med. 1995, 151: 1383-1387.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/oxfordjournals.epirev.a000805","volume":"23","author":"HJ Schunemann","year":"2001","unstructured":"Schunemann HJ, Freudenheim JL, Grant BJ: Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev. 2001, 23: 248-267. 10.1093\/oxfordjournals.epirev.a000805.","journal-title":"Epidemiol Rev"},{"key":"64_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/0960327107083452","volume":"26","author":"MS Soltan-Sharifi","year":"2007","unstructured":"Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, Mohammadirad A, Abdollahi M: Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol. 2007, 26: 697-703. 10.1177\/0960327107083452.","journal-title":"Hum Exp Toxicol"},{"key":"64_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","volume":"155","author":"VM Keatings","year":"1997","unstructured":"Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997, 155: 542-548.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR21","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1164\/ajrccm.160.5.9811058","volume":"160","author":"SV Culpitt","year":"1999","unstructured":"Culpitt SV, Nightingale JA, Barnes PJ: Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 160: 1635-1639.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.200204-298OC","volume":"167","author":"SV Culpitt","year":"2003","unstructured":"Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ: Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 167: 24-31. 10.1164\/rccm.200204-298OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"64_CR23","first-page":"1100","volume":"15","author":"K Ito","year":"2001","unstructured":"Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM: Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions inalveolarmacrophages. FASEBJ. 2001, 15: 1100-1102.","journal-title":"FASEBJ"},{"key":"64_CR24","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1128\/MCB.20.18.6891-6903.2000","volume":"20","author":"K Ito","year":"2000","unstructured":"Ito K, Barnes PJ, Adcock IM: Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1b-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000, 20: 6891-6903. 10.1128\/MCB.20.18.6891-6903.2000.","journal-title":"Mol Cell Biol"},{"key":"64_CR25","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.1073\/pnas.132556899","volume":"99","author":"K Ito","year":"2002","unstructured":"Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ: A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 2002, 99: 8921-8926. 10.1073\/pnas.132556899.","journal-title":"Proc Natl Acad Sci USA"},{"key":"64_CR26","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.48.5.1581-1585.2004","volume":"48","author":"M Desaki","year":"2004","unstructured":"Desaki M, Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H: Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-\u03baB activation. Antimicrob Agent Chemother. 2004, 48: 1581-1585. 10.1128\/AAC.48.5.1581-1585.2004.","journal-title":"Antimicrob Agent Chemother"},{"key":"64_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/jac\/dkf008","volume":"49","author":"T Kikuchi","year":"2002","unstructured":"Kikuchi T, Hagiwara K, Honda Y, Gomi K, Kobayashi T, Takahashi H, Tokue Y, Watanabe A, Nukiwa T: Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-\u03baB transcription factors. J Antimicrob Chemother. 2002, 49: 745-755. 10.1093\/jac\/dkf008.","journal-title":"J Antimicrob Chemother"},{"key":"64_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1172\/JCI114492","volume":"85","author":"CP Sommerhoff","year":"1990","unstructured":"Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest. 1990, 85: 682-689. 10.1172\/JCI114492.","journal-title":"J Clin Invest"},{"key":"64_CR29","first-page":"L294","volume":"275","author":"K Takeyama","year":"1998","unstructured":"Takeyama K, Agusti C, Ueki I, Lausier J, Cardell LO, Nadel JA: Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules. Am J Physiol. 1998, 275: L294-L302.","journal-title":"Am J Physiol"},{"key":"64_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1165\/ajrcmb.25.4.4552","volume":"25","author":"M Gorrini","year":"2001","unstructured":"Gorrini M, Lupi A, Viglio S, Pamparana F, Cetta G, Iadarola P, Powers JC, Luisetti M: Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. Am J Respir Cell Mol Biol. 2001, 25: 492-499.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"64_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1164\/ajrccm\/141.1.72","volume":"141","author":"SK Goswami","year":"1990","unstructured":"Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis. 1990, 141: 72-78.","journal-title":"Am Rev Respir Dis"},{"key":"64_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","volume":"39","author":"J Tamaoki","year":"1995","unstructured":"Tamaoki J, Takeyama K, Tagaya E, Konno K: Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agent Chemother. 1995, 39: 1688-1690. 10.1128\/AAC.39.8.1688.","journal-title":"Antimicrob Agent Chemother"},{"key":"64_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jac\/41.5.505","volume":"41","author":"TR Shryock","year":"1998","unstructured":"Shryock TR, Mortensen JE, Baumholtz M: The effects of macrolides on the expression of bacterial virulence mechanisms. J Antimicrob Chemother. 1998, 41: 505-512. 10.1093\/jac\/41.5.505.","journal-title":"J Antimicrob Chemother"},{"key":"64_CR34","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/S0924-8579(01)00393-4","volume":"18","author":"JC Pechere","year":"2001","unstructured":"Pechere JC: New perspectives on macrolide antibiotics. Int J Anti-microb Agents. 2001, 18: S93-S97.","journal-title":"Int J Anti-microb Agents"},{"key":"64_CR35","doi-asserted-by":"publisher","first-page":"62S","DOI":"10.1378\/chest.125.2_suppl.62S","volume":"125","author":"DJ Wozniak","year":"2004","unstructured":"Wozniak DJ, Keyser R: Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest. 2004, 125: 62S-69S. 10.1378\/chest.125.2_suppl.62S.","journal-title":"Chest"},{"key":"64_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/MCG.0b013e31814a4e5c","volume":"42","author":"I Mainie","year":"2008","unstructured":"Mainie I, Tutuian R, Castell DO: Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008, 42: 676-679. 10.1097\/MCG.0b013e31814a4e5c.","journal-title":"J Clin Gastroenterol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2008-2231-20-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T20:45:15Z","timestamp":1568666715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/2008-2231-20-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1186\/2008-2231-20-6","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"article-number":"6"}}